• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Systagenix Wound Management Inc.

Failure of Medtronic’s Symplicity-3 trial doesn’t mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 By MassDevice Contributors Network Leave a Comment

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

Filed Under: News Well, Wall Street Beat Tagged With: Acelity, Apax Partners, Baxter, Boston Scientific, Centaur Guernsey, Covidien, Kinetic Concepts Inc., Kona Medical, LifeCell Corp., ReCor Medical, stjudemedical, Systagenix Wound Management Inc.

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

September 3, 2014 By Brad Perriello Leave a Comment

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

The private equity owners of a trio of wound care and regenerative medicine companies said today that they’re merging Kinetic Concepts Inc., Systagenix and LifeCell into a single entity called Acelity.

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Acelity, Apax Partners, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Marketing/Public Relations, Systagenix Wound Management Inc., Wound Therapy

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

March 10, 2014 By Arezu Sarvestani Leave a Comment

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.

Filed Under: MassDevice Earnings Roundup, News Well, Regenerative Medicine Tagged With: 2013, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Q4, Systagenix Wound Management Inc., Wound Therapy

Kinetic Concepts touts tissue injector acquisition

January 28, 2014 By Arezu Sarvestani Leave a Comment

Kinetic Concepts touts tissue injector acquisition

Kinetic Concepts sister company LifeCell this week announced the acquisition of fat-injection devices from California medtech group TauTona.

LifeCell hopes to use the deal, the details of which were not disclosed, to expand its reconstructive and cosmetic portfolio with the fat grafting technology.

Filed Under: Cosmetic/Aesthetic, Mergers & Acquisitions, News Well Tagged With: Kinetic Concepts Inc., LifeCell Corp., Systagenix Wound Management Inc., TauTona Group

Kinetic Concepts slips in Q3, losses widen for Systagenix, LifeCell triad

November 13, 2013 By Arezu Sarvestani Leave a Comment

Kinetic Concepts announces 1st quarter as part of Centaur Guernsey

Sales took a minor hit for Kinetic Concepts during its 3rd quarter 2013, reporting as part of the Centaur Guernsey companies which now includes both LifeCell and Systagenix.

Filed Under: MassDevice Earnings Roundup, News Well, Regenerative Medicine Tagged With: 2013, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Q3, Systagenix Wound Management Inc., Wound Therapy

KCI closes $485M buyout of Systagenix

October 28, 2013 By Brad Perriello Leave a Comment

KCI closes $485M buyout of Systagenix
KCI closes $485M buyout of Systagenix

Kinetic Concepts Inc. said it’s closed the $485 million buyout of fellow privately owned wound-care company Systagenix, which it plans to unite with its LifeCell regenerative therapies unit.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Kinetic Concepts Inc., LifeCell Corp., Systagenix Wound Management Inc., Wound Therapy

Kinetic Concepts forms trinity with LifeCell and Systagenix

September 30, 2013 By Arezu Sarvestani Leave a Comment

Kinetic Concepts forms trinity with LifeCell and Systagenix

Just weeks after the $485 million merger of Kinetic Concepts and Systagenix, the duo plans to merge forces with LifeCell Corp., forming a 3-headed hydra of wound care, biologics and regenerative therapies.

The new company will be run by KCI president & CEO Joe Woody, with LifeCell commercial operations chief Phil Croxford as senior vice president and "permanent leader" of LifeCell, according to a joint statement.

Filed Under: Mergers & Acquisitions, News Well, Regenerative Medicine Tagged With: Kinetic Concepts Inc., LifeCell Corp., Negative-Pressure Wound Therapy, Systagenix Wound Management Inc., Wound Therapy

KCI to drop $485M on wound care company Systagenix

July 30, 2013 By Brad Perriello

KCI to drop $485M on wound care company Systagenix
KCI to drop $485M on wound care company Systagenix

Kinetic Concepts Inc. said it agreed to acquire 1 of its private wound-care peers, Systagenix, for $485 million.

San Antonio, Texas-based KCI said the deal brings a large suite of complementary advanced wound care products into its portfolio.

Filed Under: Mergers & Acquisitions, News Well, Wound Care Tagged With: Kinetic Concepts Inc., Negative-Pressure Wound Therapy, Systagenix Wound Management Inc., Wound Therapy

Medtronic lands FDA clearance, plans launch for next-gen CRM lead | Regulatory Roundup

January 30, 2012 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic Inc. (NYSE:MDT) landed FDA clearance for its DF4 high-voltage right ventricular lead for use with implantable cardiac rhythm management devices.

The DF4, which builds on Medtronic’s Sprint Quattro lead, aims to help simplify the implantation process with a redesigned port and by providing visual confirmation of the lead’s connection to the device.

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Applied Spectral Imaging, Baxano Surgical, Baxter, Cardiac Rhythm Management, CardioKinetix Inc., Charter Medical, Covidien, Cynosure Inc., Positron Corp., Systagenix Wound Management Inc., VuComp Inc.

Delcath, Systagenix, TRIGOcare and Bio-Reference Laboratories tout new deals

November 28, 2011 By MassDevice staff Leave a Comment

contracts

Delcath Systems’ (NSDQ:DCTH) agreement with the European Institute of Oncology will launch European commercialization for the New York-based company’s Chemostat organ-targeting chemotherapy system.

Under the terms of the deal, Delcath will provide the Milan, Italy-based cancer center with logistics and clinical training support for the Chemostat system, which is awaiting full CE Mark approval.

Filed Under: Diagnostics, News Well, Oncology Tagged With: Delcath Systems Inc., Group Purchasing Organizations (GPO), Systagenix Wound Management Inc.

HOLX appoints Vertex’s Stamoulis to board | Personnel Moves

November 4, 2011 By MassDevice staff Leave a Comment

Hologic Inc. (NSDQ:HOLX) appointedVertex Pharmaceuticals’ senior vice president of corporate strategy and business development to its newly expanded board of directors.

Stamoulis will also serve on the Bedford, Mass.-based company’s corporate development committee.

Filed Under: News Well Tagged With: Hologic, Personnel Moves, Systagenix Wound Management Inc., Ventus Medical Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy